Brief: Helius Medical Announces Health Canada Authorization To Market Portable Neuromodulation Stimulator Device For Treatment Of Gait Deficit Due To Mild And Moderate Symptoms From Stroke
09/03/2023 12:20
March 9 (Reuters) - Helius Medical Technologies Inc
HSDT.O :
* HELIUS MEDICAL TECHNOLOGIES ANNOUNCES AUTHORIZATION FROM
HEALTH
CANADA TO MARKET PORTABLE NEUROMODULATION STIMULATOR (PONS®)
DEVICE FOR THE TREATMENT OF GAIT DEFICIT DUE TO MILD AND
MODERATE SYMPTOMS FROM STROKE
Source text for Eikon: ID:nGNX2q0ClC
Further company coverage: HSDT.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Solana Co
See all newsBrief: Solana Co Pursuant To Prospectus Supplement, May Offer Shares Of Common Stock Of Up To $250 Million From Time To Time
Brief: Solana: On May 12, Dane C. Andreeff Resigns As CEO, President And Board Member
Solana Co Q1 revenue surges on staking rewards
Brief: Solana Company (Nasdaq Hsdt) Appoints Madelene Gani As Chief Operating Officer And Deputy CFO To Lead Next Phase Of Growth
Solana Co Q4 revenue surges on staking rewards, swings to profit